Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

ASX/BOT stock hub

ASX/BOT has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ASX/BOTis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

73.4M

Australian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

ASX/BOT

In the news

Latest news · ASX/BOT

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.9P50 20.4P75 41.2

Trailing P/En/a

P25 14.2P50 19.2P75 35.1

ROE-121.1

P25 -118.7P50 -49.4P75 -1.2

ROIC-71.2

P25 -74.7P50 -33.5P75 0.1

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ASX/BOT market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

172

Groups with data

Currency

AUD

Showing 172 of 172 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Australia
Country code	AU
Employees	11
Employees Change	5%
Employees Change Percent	83.33
Enterprise value	AUD 42.9M
Exchange	Australian Securities Exchange
Financial currency	AUD
First seen	2026-05-10
Industry	Biotechnology
Isin	AU000000BOT2
Last refreshed	2026-05-10
Market cap	AUD 73.4M
Price	AUD 0.03
Price currency	AUD
Rev Per Employee	1,992,492.55x
Sector	Healthcare
Sic	2836
Symbol	asx/BOT
Website	https://www.botanixpharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-120.77%
EV Earnings	-0.48x
EV/FCF	-0.55x
EV/Sales	1.96x
FCF yield	-106.87%
P/B ratio	1.36x
P/S ratio	3.35x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	61.11%
Gross Profit	AUD 13.4M
Gross Profit Growth	563.86%
Net Income	AUD -88.7M
Net Income Growth Years	0%
Pretax Margin	-404.72%
Profit Per Employee	AUD -8.1M
ROA	-53.38
Roa5y	-27.95
ROCE	-119.3
ROE	-121.1
Roe5y	-55.37
ROIC	-71.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.01%
Cagr3y	-31.49%
Cagr5y	-19.73%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	959.25x
Revenue Growth Q	4,271.28x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	119.61x
Revenue Growth5 Y	42.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	AUD 0.22
Assets	AUD 98.6M
Cash	AUD 31.6M
Current Assets	AUD 70.7M
Current Liabilities	AUD 27.7M
Debt	AUD 1.1M
Debt Equity	AUD 0.02
Debt FCF	AUD -0.01
Equity	AUD 54M
Interest Coverage	-12.19
Liabilities	AUD 44.6M
Long Term Assets	AUD 27.8M
Long Term Liabilities	AUD 16.9M
Net Cash	AUD 30.5M
Net Cash By Market Cap	AUD 41.57
Net Cash Growth	-35.81%
Net Debt Equity	AUD -0.57
Tangible Book Value	AUD 27.3M
Tangible Book Value Per Share	AUD 0.01
WACC	16.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.56
Inventory Turnover	0.38
Net Working Capital	AUD 11.9M
Quick ratio	1.35
Working Capital	AUD 43.1M
Working Capital Turnover	AUD 0.42

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-13.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94%
200-day SMA	0.11
3Y total return	-67.86%
50-day SMA	0.04
50-day SMA vs 200-day SMA	50under200
5Y total return	-66.67%
All Time High	0.54
All Time High Change	-94.95%
All Time High Date	2025-02-21
All Time Low	0.02
All Time Low Change	17.39%
All Time Low Date	2020-03-25
ATR	0
Beta	0.83
Beta1y	0.87
Beta2y	0.76
Ch YTD	-80
High	0.03
High52	0.47
High52 Date	2025-05-09
High52ch	-94.26%
Low	0.03
Low52	0.02
Low52 Date	2026-05-06
Low52ch	12.5%
Ma50ch	-33.5%
Price vs 200-day SMA	-75.09%
RSI	32.12
RSI Monthly	28.66
RSI Weekly	21.96
Sharpe ratio	-2.33x
Sortino ratio	-2.6
Total Return	-13.48%
Tr YTD	-80
Tr1m	-30.77%
Tr3m	-77.5%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	AUD -84.6M
Operating margin	-385.8

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,478,827,337%
Net Borrowing	28,058,824
Shares Insiders	6.64%
Shares Institutions	16.24%
Shares Out	2,720,262,800
Shares Qo Q	4.87%
Shares Yo Y	13.48%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	AUD -99M
Average Volume	33,885,287x
Bv Per Share	0.03
CAPEX	AUD -198,176
Ch1m	-30.77
Ch1y	-94
Ch3m	-77.5
Ch3y	-67.86
Ch5y	-66.67
Ch6m	-79.23
Change	8%
Change From Open	3.85
Close	0.03
Days Gap	4
Depreciation Amortization	2,332,116
Dollar Volume	370,230.6
Earnings Date	2026-05-28
EBIT	AUD -84.6M
EBITDA	AUD -82.2M
EPS	AUD -0.05
F Score	3
FCF	AUD -78.5M
FCF EV Yield	-182.91x
FCF Per Share	AUD -0.03
Financing CF	62,401,703
Fiscal Year End	June
Founded	1,984
Investing CF	-637,530
Is Primary Listing	1
Last Earnings Date	2026-03-04
Last Report Date	2025-12-31
Ma150	0.1
Ma150ch	-71.96%
Ma20	0.03
Ma20ch	-13.74%
Net CF	-16,824,357
Next Earnings Date	2026-05-28
Open	0.03
Position In Range	100
Ppne	1,128,301
Price Date	2026-05-08
Ptbv Ratio	2.69
Relative Volume	0.41x
Revenue	21,917,418x
SBC By Revenue	93.61x
Share Based Comp	20,516,949
Tr6m	-79.23%
Volume	13,712,244
Z Score	1.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ASX/BOT pay a dividend?

Capital-return profile for this ticker.

Performance

ASX/BOT stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ASX/BOT?

Insider, institutional, and short-interest positioning.

Institutional ownership

+16.2%

Share of float held by funds and institutions

Insider ownership

+6.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+13.5%

Negative means the company is buying back shares.

Technical

ASX/BOT momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

32.1

Neutral momentum band

Price vs 200-day MA

-75.1%

50/200-day relationship not available

Beta (5Y)

0.83

Moves roughly with the market

Sharpe ratio

-2.33

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ASX/BOT

Hub-level FAQ points readers to the deeper analysis pages.

What is the current asx/BOT stock rating?

asx/BOT is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full asx/BOT analysis?

The full report lives at /stocks/asx/BOT/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for asx/BOT?

The latest report frames asx/BOT around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the asx/BOT page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.